In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Deals Financing Market Intelligence

Deals In Depth: October 2022

  • Analysis

Executive Summary

Two $1bn+ alliances were penned in October. Financing reached $7.7bn in biopharma, $636m in device, and $140m in diagnostics.

You may also be interested in...



Minute Insight: Thermo Fisher Buys Diagnostics Company The Binding Site For $2.6Bn

Birmingham, UK-based The Binding Site and its 1,100 employees will now fall under Thermo Fisher’s expanding umbrella.

Zymeworks Deal Expands Jazz’s Potential Oncology Presence

The deal focuses on the HER2-targeting bispecific antibody zanidatamab, in development for multiple solid tumor indications expressing HER2.

Deals In Depth: December 2022

The year's biggest M&A deal, along with billion dollar alliances marked out December's dealmaking credentials.

Table

View full table

Topics

Related Companies

Tags:
Deals Financing Market Intelligence
Latest Headlines

Slew Of Challenges Calls For Revised Biopharma Playbook

Roivant Is Striving Towards New Standards Of Care

The Mandate To Make A Digital Difference

Snapshot: January Highlights

See All
UsernamePublicRestriction

Register

IV146766

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By